Skip to content

Dr Cherif

Active Private limited companyfounded 2023active for 3 yearsAdelaarsstraat 6, 9051 GhentKBO/BCE: BE 1000.394.751

Lifetime

3 annual accounts with figures on one time axis
peak of €382,476 in 2025
€382,476▲ 57.0%
peak of €237,589 in 2025
€237,589▲ 41.2%
peak of €468,157 in 2025
€468,157▲ 94.3%
€155,923▲ 89.6%
Board1 name since 2023
1 director
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from €243,664 to €382,476Result from €168,247 to €237,589Merger: DR CHERIF takes over CACTUS 14-04Merger proposal: Dr Cherif takes over Cactus Comm.V. 24-02Equity from €240,902 to €468,157Debts from €82,234 to €155,923

Key points

from the 2025 annual accounts

Equity

€468,157 ▲ 94.3%
€241,0002024€468,0002025

Equity rose in 2025: merger with CACTUS.

Turnover

≈ €770,000 estimated

The micro format states no turnover.

Debts

€155,923 ▲ 89.6%
Taxes and wages
+71,707
Suppliers
+2,726
The rest
-743

Debts rose by €73,689 in 2025.

Investments

€371,620 7.9 times depreciation

Green is investment, beige is depreciation.

Liquidity

2.06 was 4.19 in 2024

Short-term debts rose from €77,081 to €151,513.

Filings

3 annual accounts 61 days
AprilJune31 JulyOctober202320242025

Latest accounts filed late: after the legal deadline.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,138 companies had the same profile as Dr Cherif has now. Each dot stands for 8 companies, two years later.

97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
  • Small
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,138 companies, not a prediction for Dr Cherif. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 24-02-2025
Board & ownership

Recent changes

Merger: DR CHERIF takes over CACTUS Dissolution of the company · Capital increase of €700 to €73,355.25 · Dissolved without liquidation on 31-03-2025 · General meeting of 31-03-2025 · Gazette deed
Merger proposal: Dr Cherif takes over Cactus Comm.V. holds 99 shares · The company holds 1 share of Cactus Comm.V. · holds 100 shares · Gazette deed
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 29-09-2023 · Gazette deed
First establishment Adelaarsstraat 6, Ghent
All 9 events

Official details

Source: KBO
Status
Active since 27-09-2023Normal situation
Activity
“De uitoefening door de artsen-vennoten van hun zelfstandige medische activiteit als spoedarts door de…” (deed in Dutch)From the articles, 15 activities1 activity on the establishment unit
Establishment unit
2.351.008.0049051 Ghent, since 27-09-2023
Financial year end
31 December
Peppol
Reachable
Company details

Annual accounts 2025

€624,080▲ 93.1%
Filing
Filed on 30-09-2026
Financials

Insights on Dr Cherif

Dr Cherif files the micro format. That format states no turnover. The gross margin rose from €94,359 in 2023 to €382,476 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr Cherif

What is the company number of Dr Cherif?
The company number of Dr Cherif is 1000.394.751. The VAT number is the same number with BE in front: BE 1000.394.751.
Where is Dr Cherif based?
The registered office is at Adelaarsstraat 6, 9051 Ghent.Company details
What is the legal form of Dr Cherif?
Dr Cherif is a private limited company (BV).
When was Dr Cherif founded?
Dr Cherif was founded on 27-09-2023.
Is Dr Cherif still active?
Yes, Dr Cherif is an active enterprise in the KBO register.
What is the turnover of Dr Cherif?
The turnover in financial year 2025 is ≈ €770,000. This figure is estimated from the gross margin of €382,476 and 1,018 comparable companies of the same size. It probably lies between €530,000 and €1.1m. It is a rough estimate.Financials
Is Dr Cherif profitable?
In financial year 2025, Dr Cherif made a profit of €237,589.
Where can I find the annual accounts of Dr Cherif?
Dr Cherif filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr Cherif due?
Dr Cherif must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.